01 January 1999
Blood fructosamine levels in patients with primary and metastatic brain tumors
Barbara Chmielewska, Ewa Belniak-Legieć, Zbigniew StelmasiakMed Sci Monit 1999; 5(1): CR58-61 :: ID: 505219
Abstract
Hyperglikemia increases the blood protein glycosylated reaction. Central nervous system (CNS) organic diseases may change the systemic metabolism. The aim of this study was to evaluate blood glycosylated protein levels (fructosamine - FA) in patients with CNS tumors. Patients were divided into two groups: those with a primary brain tumor (n=12, mean age - 58 years) and those with a metastatic brain tumor (n=12, mean age - 57.9), without diabetes or cachexy. Their protein, albumin and glucose levels were within normal values. We determined FA levels by means of the frustosamine reductive method in relation to nitrotetrazoline blue, using the Boehringer Mannheim GmbH Diagnostica set. p < 0.02 was considered as statistically significant, evaluated by means of the Mann-Whitney U test. The control group comprised 11 patients (mean age - 63.7 years). We noted an increase in fructosamine levels in patients with CNS tumors. A statistically significant difference was observed in patients with metastatic tumors, in comparison with controls (287.8 µmol/l vs. 214.9 µmol/l). An elevation in FA levels was evidence of increased glycosylation, in CNS tumor patients, due to an increase of mean glucose values in the past 2-4 weeks.
Keywords: primary brain tumors, serum fructosamine level, adults
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952